Using a modified Delphi procedure to select a PRO-CTCAE-based subset for patient-reported symptomatic toxicity monitoring in rectal cancer patients
Based on a comprehensive mixed methods study, a PRO-CTCAE subset for standardized treatment-related symptomatic toxicity monitoring in rectal cancer was identified. Assessment of the effectiveness and compliance of symptomatic toxicity monitoring using this subset is recommended.
Authors
- Kelly M. de Ligt (ORCID: https://orcid.org/0000-0001-9218-617X)
- Femke P. Peters (ORCID: https://orcid.org/0000-0001-9085-447X)
- Martijn Intven (ORCID: https://orcid.org/0000-0002-5068-5517)
- Y.M. Geurts (ORCID: https://orcid.org/0000-0001-9010-4919)
- Marcel Verheij (ORCID: https://orcid.org/0000-0002-8079-7421)
- Jan Willem T. Dekker (ORCID: https://orcid.org/0000-0002-3429-468X)
- Iris Walraven
- Jeanine M.L. Roodhart (ORCID: https://orcid.org/0000-0003-1398-8970)
- Milan C. Richir (ORCID: https://orcid.org/0000-0001-5523-083X)
- Jeltsje S. Cnossen
- Geerard L. Beets (ORCID: https://orcid.org/0000-0002-1671-9912)
- Esther Feldman
- Patricia D Bottenberg
Institutions
- Radboud University Nijmegen (NL)
- Catharina Ziekenhuis (NL)
- Radboud University Medical Center (NL)
- The Netherlands Cancer Institute (NL)
- University Medical Center Utrecht (NL)
- Maastricht University (NL)
- Reinier de Graaf Hospital (NL)
- Radboud Institute for Molecular Life Sciences (NL)
- Oncode Institute (NL)
Publication Details
- Journal
- Quality of Life Research
- Published
- 2024-09-08
- DOI
- https://doi.org/10.1007/s11136-024-03767-0
- Citations
- 1
- Primary Topic
- Cancer survivorship and care
- Type
- article
- Field-Weighted Citation Impact
- 0.28
Funders
- Stichting Kwaliteitsgelden Medisch Specialisten